Fig. 1From: Post-progression treatment in cancer randomized trials: a cross-sectional study of trials leading to FDA approval and published trials between 2018 and 2020Flow charts of the top journal publications selection process (left panel), and of the FDA registration trials selection process (right panel)Back to article page